H.I.G. Capital’s Strategic Investments Reshape Healthcare and Beyond

H.I.G. Capital continues to make significant strides in the healthcare sector, reinforcing its position as a leading global alternative investment firm. With $65 billion in assets under management, the Miami-based firm has been actively diversifying its portfolio, with a keen focus on growth and innovation in both healthcare and related sectors.

A notable acquisition by H.I.G. Capital is that of SkinCure Oncology, a company specializing in non-invasive cancer treatments. This acquisition aligns with the growing demand for less invasive therapies, propelling H.I.G. into a promising market. SkinCure Oncology’s GentleCure™ platform is expected to drive further advancements under the new ownership.

In a parallel move, H.I.G. Capital announced the sale of BIOVECTRA, which marks a strategic exit from a successful venture in the pharmaceutical manufacturing space. The sale to Agilent Technologies, Inc. for $925 million underscores the firm’s ability to capitalize on its investments and refocus resources on emerging opportunities.

Diversifying further, H.I.G. Capital’s acquisition of Naturalia Tantum S.p.A highlights its foray into the organic and natural products sphere. This Italian company is known for its range of beauty and personal care products, tapping into the growing consumer preference for organic solutions.

Additionally, H.I.G. Capital’s purchase of Action Elevator, although outside traditional healthcare, strengthens its foothold in services crucial to healthcare infrastructure. This acquisition, along with Action’s acquisition of Century Elevator, expands H.I.G.’s presence in the Mid-Atlantic region.

As H.I.G. Capital continues to navigate the investment landscape, its strategic decisions reflect a commitment to sectors that promise robust growth and innovation. Whether through acquisitions or strategic sales, the firm is adeptly positioning itself to lead in the dynamic healthcare and adjacent markets.

H.I.G. Capital continues to make significant strides in the healthcare sector, reinforcing its position as a leading global alternative investment firm. With $65 billion in assets under management, the Miami-based firm has been actively diversifying its portfolio, with a keen focus on growth and innovation in both healthcare and related sectors. A notable acquisition by…